Closure of Iatrogenic Atrial Septal Defect After Transcatheter Mitral Valve Repair: The Randomized MITHRAS Trial

Circulation. 2021 Jan 19;143(3):292-294. doi: 10.1161/CIRCULATIONAHA.120.051989. Epub 2020 Oct 15.

Authors

Affiliations

¹ Department of Internal Medicine/Cardiology (P.L., M.U., K.-P.R., K.-P.K., T.K., C.B., K.F., M.S., H.T., M.v.R., S.B.), Heart Center Leipzig at Leipzig University, Germany.
² Leipzig Heart Institute, Germany (P.L., H.T.).
³ Department of Pediatric Cardiology (I.D.), Heart Center Leipzig at Leipzig University, Germany.

^# Contributed equally.

PMID: 33054368
DOI: 10.1161/CIRCULATIONAHA.120.051989

No abstract available

Keywords: atrial septal defect; heart failure; mitral regurgitation.

Publication types

Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Cardiac Catheterization / methods*
Echocardiography, Transesophageal / methods
Female
Follow-Up Studies
Heart Septal Defects, Atrial / diagnostic imaging
Heart Septal Defects, Atrial / surgery*
Humans
Male
Mitral Valve / diagnostic imaging
Mitral Valve / surgery*
Treatment Outcome
Walk Test / methods